Fresolimumab (GC1008) is a specific human anti-transforming growth factor beta monoclonal antibody that binds to the active forms of human TGFbeta1, TGFbeta2, and TGFbeta3 and can be used to study focal segmental glomerulosclerosis and cancer in adults.
CAS Number:
[948564-73-6]
Target:
GC1008
* VAT and and shipping costs not included. Errors and price changes excepted